Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

Important achievements from across our portfolio of companies helped drive record revenue and continued success in the opening months of 2019. Medical Marijuana, Inc. and our portfolio of companies and investments continued our upward trend in the first fiscal quarter of 2019, tallying record revenue from January to March. Medical Marijuana, Inc.’s Q1 2019 revenue […]

AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

Medical Marijuana, Inc. investment AXIM® Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM® Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). The provisional patent application is for a patent on […]